miR-647 inhibits hepatocellular carcinoma cell progression by targeting protein tyrosine phosphatase receptor type F

Hepatocellular carcinoma (HCC) is a kind of malignant tumor derived from hepatocytes and hepatobiliary cells, and its occurrence is prevalent worldwide. Although medical technology is developing rapidly, the therapeutic efficacy of HCC is still poor. Emerging evidence manifests that microRNAs (miRNA...

Descripción completa

Detalles Bibliográficos
Autores principales: Ye, Xiangyang, Qiu, Rongxian, He, Xiongzhi, Hu, Zhengting, Zheng, Fengfeng, Huang, Xiaogang, Xie, Xuemei, Chen, Feihua, Ou, Hangbing, Lin, Guoxian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8805897/
https://www.ncbi.nlm.nih.gov/pubmed/34969357
http://dx.doi.org/10.1080/21655979.2021.2017628

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8805897/
https://www.ncbi.nlm.nih.gov/pubmed/34969357
http://dx.doi.org/10.1080/21655979.2021.2017628

Ejemplares similares